{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:12:22Z","timestamp":1792498342709,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11198-4","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:04:26Z","timestamp":1761728666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential of Benfotiamine in the treatment of neuropsychological disorders"],"prefix":"10.1007","volume":"53","author":[{"given":"Alireza","family":"Motamedzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Karimzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felora","family":"Ferdosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rahmati-Dehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Dadgostar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atie","family":"Validad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyamin","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid Reza","family":"Tamtaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"11198_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020355","volume":"11","author":"S Ribari\u010d","year":"2023","unstructured":"Ribari\u010d S (2023) Detecting early cognitive decline in Alzheimer\u2019s disease with brain synaptic structural and functional evaluation. Biomedicines 11:355","journal-title":"Biomedicines"},{"key":"11198_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","volume":"29","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ (2008) Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 29:676\u2013692","journal-title":"Neurobiol Aging"},{"key":"11198_CR3","doi-asserted-by":"crossref","unstructured":"Bettendorff L (2020) Thiamine. Present knowledge in nutrition. Elsevier, pp 171\u2013188","DOI":"10.1016\/B978-0-323-66162-1.00010-X"},{"issue":"11","key":"11198_CR4","doi-asserted-by":"publisher","first-page":"e21839","DOI":"10.1016\/j.heliyon.2023.e21839","volume":"9","author":"I Bozic","year":"2023","unstructured":"Bozic I, Lavrnja I (2023) Thiamine and benfotiamine: focus on their therapeutic potential. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21839","journal-title":"Heliyon"},{"key":"11198_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ecam\/nek009","volume":"3","author":"D Lonsdale","year":"2006","unstructured":"Lonsdale D (2006) A review of the biochemistry, metabolism and clinical benefits of thiamin (e) and its derivatives. Evidence-Based Complementary and Alternative Medicine 3:49\u201359","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"11198_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.phrs.2010.02.008","volume":"61","author":"P Balakumar","year":"2010","unstructured":"Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A (2010) The multifaceted therapeutic potential of Benfotiamine. Pharmacol Res 61:482\u2013488","journal-title":"Pharmacol Res"},{"key":"11198_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118372","volume":"10","author":"I Bozic","year":"2015","unstructured":"Bozic I, Savic D, Laketa D, Bjelobaba I, Milenkovic I, Pekovic S, Nedeljkovic N, Lavrnja I (2015) Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia. PLoS ONE 10:e0118372","journal-title":"PLoS ONE"},{"key":"11198_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquaculture.2023.739553","volume":"572","author":"L Zhang","year":"2023","unstructured":"Zhang L, Ge Y-P, Huang Y-Y, Chen W-L, Liu W-B, Zhang D-D, Li X-F (2023) Benfotiamine attenuates the high-carbohydrate diet-induced mitochondrial redox imbalance in fish megalobrama amblycephala by activating SIRT3. Aquaculture 572:739553","journal-title":"Aquaculture"},{"key":"11198_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.996030","volume":"14","author":"S Murakami","year":"2022","unstructured":"Murakami S, Lacayo P (2022) Biological and disease hallmarks of Alzheimer\u2019s disease defined by Alzheimer\u2019s disease genes. Front Aging Neurosci 14:996030","journal-title":"Front Aging Neurosci"},{"key":"11198_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1033272","volume":"9","author":"GE Gibson","year":"2022","unstructured":"Gibson GE, Feldman HH, Zhang S, Flowers SA, Luchsinger JA (2022) Pharmacological thiamine levels as a therapeutic approach in Alzheimer\u2019s disease. Front Med 9:1033272","journal-title":"Front Med"},{"key":"11198_CR11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jhep.2013.10.011","volume":"60","author":"CR Bosoi","year":"2014","unstructured":"Bosoi CR, Zwingmann C, Marin H, Parent-Robitaille C, Huynh J, Tremblay M, Rose CF (2014) Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. J Hepatol 60:554\u2013560","journal-title":"J Hepatol"},{"key":"11198_CR12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuint.2013.01.009","volume":"62","author":"AS Hazell","year":"2013","unstructured":"Hazell AS, Faim S, Wertheimer G, Silva VR, Marques CS (2013) The impact of oxidative stress in thiamine deficiency: a multifactorial targeting issue. Neurochem Int 62:796\u2013802","journal-title":"Neurochem Int"},{"key":"11198_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11064-014-1430-z","volume":"40","author":"E Abdou","year":"2015","unstructured":"Abdou E, Hazell AS (2015) Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations. Neurochem Res 40:353\u2013361","journal-title":"Neurochem Res"},{"key":"11198_CR14","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3233\/JAD-160841","volume":"55","author":"L Szablewski","year":"2016","unstructured":"Szablewski L (2016) Glucose transporters in brain: in health and in Alzheimer\u2019s disease. J Alzheimers Dis 55:1307\u20131320","journal-title":"J Alzheimers Dis"},{"key":"11198_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-2-12","volume":"2","author":"CA Rankin","year":"2007","unstructured":"Rankin CA, Sun Q, Gamblin TC (2007) Tau phosphorylation by GSK-3\u03b2 promotes tangle-like filament morphology. Mol Neurodegener 2:1\u201314","journal-title":"Mol Neurodegener"},{"key":"11198_CR16","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s10495-010-0481-0","volume":"15","author":"Y Wang","year":"2010","unstructured":"Wang Y, Qin Z-h (2010) Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15:1382\u20131402","journal-title":"Apoptosis"},{"key":"11198_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.pbb.2006.03.004","volume":"83","author":"FM Carvalho","year":"2006","unstructured":"Carvalho FM, Pereira SR, Pires RG, Ferraz VP, Romano-Silva MA, Oliveira-Silva IF, Ribeiro AM (2006) Thiamine deficiency decreases glutamate uptake in the prefrontal cortex and impairs spatial memory performance in a water maze test. Pharmacol Biochem Behav 83:481\u2013489","journal-title":"Pharmacol Biochem Behav"},{"key":"11198_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuroscience.2015.03.046","volume":"295","author":"J Detka","year":"2015","unstructured":"Detka J, Kurek A, Kucharczyk M, G\u0142ombik K, Basta-Kaim A, Kubera M, Laso\u0144 W, Budziszewska B (2015) Brain glucose metabolism in an animal model of depression. Neuroscience 295:198\u2013208","journal-title":"Neuroscience"},{"key":"11198_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s13105-013-0242-y","volume":"69","author":"A Sharma","year":"2013","unstructured":"Sharma A, Bist R, Bubber P (2013) Thiamine deficiency induces oxidative stress in brain mitochondria of Mus musculus. J Physiol Biochem 69:539\u2013546","journal-title":"J Physiol Biochem"},{"key":"11198_CR20","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.neurobiolaging.2007.12.013","volume":"30","author":"SS Karuppagounder","year":"2009","unstructured":"Karuppagounder SS, Xu H, Shi Q, Chen LH, Pedrini S, Pechman D, Baker H, Beal MF, Gandy SE, Gibson GE (2009) Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer\u2019s mouse model. Neurobiol Aging 30:1587\u20131600","journal-title":"Neurobiol Aging"},{"key":"11198_CR21","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1021\/acschemneuro.4c00113","volume":"15","author":"CA Cardinali","year":"2024","unstructured":"Cardinali CA, Martins YA, Moraes RC, Costa AP, Alencar MB, Silber AM, Torr\u00e3o AS (2024) Exploring the therapeutic potential of Benfotiamine in a sporadic Alzheimer\u2019s-like disease rat model: insights into insulin signaling and cognitive function. ACS Chem Neurosci 15:2982\u20132994","journal-title":"ACS Chem Neurosci"},{"key":"11198_CR22","doi-asserted-by":"crossref","unstructured":"Cardinali C, Martins YA, Moraes CM, Costa R AP and, Torr\u00e3o AS (2025) Benfotiamine ameliorates Streptozotocin-Induced alzheimer\u2019s disease in rats by modulating Neuroinflammation, oxidative Stress, and microglia. Mol Neurobiol 62:1\u201323","DOI":"10.1007\/s12035-025-04811-x"},{"key":"11198_CR23","doi-asserted-by":"crossref","unstructured":"de Moraes RCM, Singulani MP, de Gon\u00e7alves AC, Portari GV and da, Silva Torr\u00e3o A (2020) Oral benfotiamine reverts cognitive deficit and increase thiamine diphosphate levels in the brain of a rat model of neurodegeneration. Experimental Gerontology 141:111097","DOI":"10.1016\/j.exger.2020.111097"},{"key":"11198_CR24","doi-asserted-by":"crossref","unstructured":"de Moraes RCM, Lima GCA, Cardinali CAEF, Gon\u00e7alves AC, Portari GV, Guerra-Shinohara EM, Leboucher A, J\u00fanior JD, Kleinridders A and da, Silva Torr\u00e3o A (2022) Benfotiamine protects against hypothalamic dysfunction in a STZ-induced model of neurodegeneration in rats. Life Sciences 306:120841","DOI":"10.1016\/j.lfs.2022.120841"},{"key":"11198_CR25","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/brain\/awq069","volume":"133","author":"X Pan","year":"2010","unstructured":"Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z (2010) Powerful beneficial effects of benfotiamine on cognitive impairment and \u03b2-amyloid deposition in amyloid precursor protein\/presenilin-1 transgenic mice. Brain 133:1342\u20131351","journal-title":"Brain"},{"key":"11198_CR26","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1093\/hmg\/ddy201","volume":"27","author":"V Tapias","year":"2018","unstructured":"Tapias V, Jainuddin S, Ahuja M, Stack C, Elipenahli C, Vignisse J, Gerges M, Starkova N, Xu H, Starkov AA (2018) Benfotiamine treatment activates the Nrf2\/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy. Hum Mol Genet 27:2874\u20132892","journal-title":"Hum Mol Genet"},{"key":"11198_CR27","first-page":"127","volume":"176","author":"B Mallika","year":"2025","unstructured":"Mallika B, Sudha K, Massand A, Murlimanju B, Sonal G, Neelam M, Sowndarya K (2025) Evaluation of neuroprotective role of Benfotiamine in alzheimer\u2019s disease model: a randomized control study. Clin Ter 176:127\u2013135","journal-title":"Clin Ter"},{"key":"11198_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3233\/JAD-200896","volume":"78","author":"GE Gibson","year":"2020","unstructured":"Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM (2020) Benfotiamine and cognitive decline in Alzheimer\u2019s disease: results of a randomized placebo-controlled phase IIa clinical trial. J Alzheimers Dis 78:989\u20131010","journal-title":"J Alzheimers Dis"},{"key":"11198_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-016-0775-x","volume":"16","author":"LA Zilliox","year":"2016","unstructured":"Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW (2016) Diabetes and cognitive impairment. Curr Diab Rep 16:1\u201311","journal-title":"Curr Diab Rep"},{"key":"11198_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155565","volume":"144","author":"D Ziegler","year":"2023","unstructured":"Ziegler D, Reiners K, Strom A, Obeid R (2023) Association between diabetes and thiamine status-a systematic review and meta-analysis. Metabolism 144:155565","journal-title":"Metabolism"},{"key":"11198_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12640-010-9204-0","volume":"19","author":"J Zhao","year":"2011","unstructured":"Zhao J, Sun X, Yu Z, Pan X, Gu F, Chen J, Dong W, Zhao L, Zhong C (2011) Exposure to pyrithiamine increases \u03b2-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain. Neurotox Res 19:575\u2013583","journal-title":"Neurotox Res"},{"key":"11198_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"L Yang","year":"2018","unstructured":"Yang L, Wang H, Liu L, Xie A (2018) The role of insulin\/IGF-1\/PI3K\/Akt\/GSK3\u03b2 signaling in parkinson\u2019s disease dementia. Front NeuroSci 12:73","journal-title":"Front NeuroSci"},{"key":"11198_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","volume":"339","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Huang N-q, Yan F, Jin H, Zhou S-y, Shi J-s, Jin F (2018) Diabetes mellitus and Alzheimer\u2019s disease: GSK-3\u03b2 as a potential link. Behav Brain Res 339:57\u201365","journal-title":"Behav Brain Res"},{"key":"11198_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2174\/1567205016666190827112546","volume":"16","author":"B Du","year":"2019","unstructured":"Du B, Lian Y, Chen C, Zhang H, Bi Y, Fan C, Bi X (2019) Strong association of serum GSK-3\u03b2\/BDNF ratio with mild cognitive impairment in elderly type 2 diabetic patients. Curr Alzheimer Res 16:1151\u20131160","journal-title":"Curr Alzheimer Res"},{"key":"11198_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12035-014-8632-x","volume":"50","author":"AK Datusalia","year":"2014","unstructured":"Datusalia AK, Sharma SS (2014) Amelioration of diabetes-induced cognitive deficits by GSK-3\u03b2 inhibition is attributed to modulation of neurotransmitters and neuroinflammation. Mol Neurobiol 50:390\u2013405","journal-title":"Mol Neurobiol"},{"key":"11198_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/878123","volume":"2014","author":"Z-S Qu","year":"2014","unstructured":"Qu Z-S, Li L, Sun X-J, Zhao Y-W, Zhang J, Geng Z, Fu J-L, Ren Q-G (2014) Glycogen synthase kinase-3 regulates production of amyloid\u2010\u03b2 peptides and tau phosphorylation in diabetic rat brain. Sci World J 2014:878123","journal-title":"Sci World J"},{"key":"11198_CR37","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2020.18.1.81","volume":"18","author":"M Safavi","year":"2020","unstructured":"Safavi M, Hosseini-Sharifabad A, Seyed-Yousefi Y, Rabbani M (2020) Protective effects of citicoline and benfotiamine each alone and in combination on streptozotocin-induced memory impairment in mice. Clin Psychopharmacol Neurosci 18:81","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"11198_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2005.10.022","volume":"394","author":"S Wu","year":"2006","unstructured":"Wu S, Ren J (2006) Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-\u03b1. Neurosci Lett 394:158\u2013162","journal-title":"Neurosci Lett"},{"key":"11198_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134316","volume":"709","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Trojanowski JQ, Lee VM-Y (2019) \u03b1-Synuclein pathology in Parkinson\u2019s disease and related \u03b1-synucleinopathies. Neurosci Lett 709:134316","journal-title":"Neurosci Lett"},{"key":"11198_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0304-3940(99)00515-7","volume":"271","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"1999","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Molina JA, Hern\u00e1nz A, Fern\u00e1ndez-Vivancos E, de Bustos F, Barcenilla B, G\u00f3mez-Escalonilla C, Zurdo Mn, Berbel A, Villanueva C (1999) Cerebrospinal fluid levels of thiamine in patients with Parkinson\u2019s disease. Neurosci Lett 271:33\u201336","journal-title":"Neurosci Lett"},{"key":"11198_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clnesp.2020.03.012","volume":"37","author":"L H\u00e5glin","year":"2020","unstructured":"H\u00e5glin L, Domell\u00f6f M, B\u00e4ckman L, Forsgren L (2020) Low plasma thiamine and phosphate in male patients with Parkinson\u2019s disease is associated with mild cognitive impairment. Clin Nutr ESPEN 37:93\u201399","journal-title":"Clin Nutr ESPEN"},{"key":"11198_CR42","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1007\/s12035-016-0079-9","volume":"54","author":"D Liu","year":"2017","unstructured":"Liu D, Ke Z, Luo J (2017) Thiamine deficiency and neurodegeneration: the interplay among oxidative stress, Endoplasmic reticulum stress, and autophagy. Mol Neurobiol 54:5440\u20135448","journal-title":"Mol Neurobiol"},{"key":"11198_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040955","volume":"12","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti S, Bisaglia M (2023) Oxidative stress and neuroinflammation in Parkinson\u2019s disease: the role of dopamine oxidation products. Antioxidants 12:955","journal-title":"Antioxidants"},{"key":"11198_CR44","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.4314\/tjpr.v18i5.18","volume":"18","author":"Y Dong","year":"2019","unstructured":"Dong Y, Xu Q, Jia X, Li C, Xu D, Jiao Y (2019) Neuroprotective effect of thiamine triethylorthoformate conjugate against Parkinson disease in a mouse model. Trop J Pharm Res 18:1041\u20131047","journal-title":"Trop J Pharm Res"},{"key":"11198_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176234","volume":"962","author":"B Bashir","year":"2024","unstructured":"Bashir B, Mittal S, Muthukumar A, Vishwas S, Pandey NK, Gulati M, Gupta G, Dhanasekaran M, Kumar P, Dureja H (2024) Harnessing the neuroprotective effect of oral administration of Benfotiamine in MPTP induced parkinson\u2019s disease in rats. Eur J Pharmacol 962:176234","journal-title":"Eur J Pharmacol"},{"key":"11198_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307012","volume":"19","author":"K Wang","year":"2024","unstructured":"Wang K, Han C, Yang J, Xu W, Wang L, Li H, Wang Y (2024) Benfotiamine protects MPTP-induced parkinson\u2019s disease mouse model via activating Nrf2 signaling pathway. PLoS ONE 19:e0307012","journal-title":"PLoS ONE"},{"key":"11198_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-019-0997-0","volume":"21","author":"J Rehm","year":"2019","unstructured":"Rehm J, Shield KD (2019) Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep 21:1\u20137","journal-title":"Curr Psychiatry Rep"},{"key":"11198_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2217\/fnl-2017-0039","volume":"13","author":"A Halaris","year":"2018","unstructured":"Halaris A (2018) Neuroinflammation and neurotoxicity contribute to neuroprogression in neurological and psychiatric disorders. Future Neurol 13:59\u201369","journal-title":"Future Neurol"},{"key":"11198_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/diseases7010022","volume":"7","author":"S Matsuda","year":"2019","unstructured":"Matsuda S, Ikeda Y, Murakami M, Nakagawa Y, Tsuji A, Kitagishi Y (2019) Roles of PI3K\/AKT\/GSK3 pathway involved in psychiatric illnesses. Diseases 7:22","journal-title":"Diseases"},{"key":"11198_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pnpbp.2016.11.001","volume":"75","author":"N Markova","year":"2017","unstructured":"Markova N, Bazhenova N, Anthony DC, Vignisse J, Svistunov A, Lesch K-P, Bettendorff L, Strekalova T (2017) Thiamine and benfotiamine improve cognition and ameliorate GSK-3\u03b2-associated stress-induced behaviours in mice. Prog Neuropsychopharmacol Biol Psychiatry 75:148\u2013156","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"11198_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.mcn.2017.05.005","volume":"82","author":"J Vignisse","year":"2017","unstructured":"Vignisse J, Sambon M, Gorlova A, Pavlov D, Caron N, Malgrange B, Shevtsova E, Svistunov A, Anthony DC, Markova N (2017) Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels. Mol Cell Neurosci 82:126\u2013136","journal-title":"Mol Cell Neurosci"},{"key":"11198_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.02.025","volume":"156","author":"A Gorlova","year":"2019","unstructured":"Gorlova A, Pavlov D, Anthony DC, Ponomarev ED, Sambon M, Proshin A, Shafarevich I, Babaevskaya D, Les\u0441h K-P, Bettendorff L (2019) Thiamine and benfotiamine counteract ultrasound-induced aggression, normalize AMPA receptor expression and plasticity markers, and reduce oxidative stress in mice. Neuropharmacology 156:107543","journal-title":"Neuropharmacology"},{"key":"11198_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","volume":"101","author":"NB Finnerup","year":"2021","unstructured":"Finnerup NB, Kuner R, Jensen TS (2021) Neuropathic pain: from mechanisms to treatment. Physiol Rev 101:259\u2013301","journal-title":"Physiol Rev"},{"key":"11198_CR54","first-page":"308","volume":"5","author":"CQ Cui","year":"2014","unstructured":"Cui CQ, Qiu LL (2014) Thiamine deficiency (beriberi) induced polyneuropathy and cardiomyopathy: case report and review of the literature. J Med Cases 5:308\u2013311","journal-title":"J Med Cases"},{"key":"11198_CR55","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1055\/s-2001-17399","volume":"109","author":"H Stracke","year":"2001","unstructured":"Stracke H, Hammes H, Werkmann D, Mavrakis K, Bitsch I, Netzel M, Geyer J, K\u00f6pcke W, Sauerland C, Bretzel R (2001) Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes 109:330\u2013336","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"11198_CR56","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.37358\/RC.19.9.7498","volume":"70","author":"AR Popa","year":"2019","unstructured":"Popa AR, Bungau S, Vesa CM, Bondar AC, Pantis C, Maghiar O, Dimulescu IA, Nistor-Cseppento D, Rus M (2019) Evaluating the efficacy of the treatment with Benfotiamine and alpha-lipoic acid in distal symmetric painful diabetic polyneuropathy. Rev Chim 70:3108\u20133114","journal-title":"Rev Chim"},{"key":"11198_CR57","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0033-1363977","volume":"122","author":"C Nacitarhan","year":"2014","unstructured":"Nacitarhan C, Minareci E, Sadan G (2014) The effect of Benfotiamine on mu-opioid receptor mediated antinociception in experimental diabetes. Exp Clin Endocrinol Diabetes 122:173\u2013178","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"11198_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40200-020-00666-2","volume":"20","author":"L Vafadar Ghasemi","year":"2021","unstructured":"Vafadar Ghasemi L, Behnam Rassouli M, Matin MM, Mahdavi-Shahri N (2021) Benfotiamine reduced collagen IV contents of sciatic nerve in hyperglycemic rats. J Diabetes Metab Disord 20:21\u201330","journal-title":"J Diabetes Metab Disord"},{"key":"11198_CR59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1358\/mf.2008.30.6.1232963","volume":"30","author":"T Mixcoatl-Zecuatl","year":"2008","unstructured":"Mixcoatl-Zecuatl T, Qui\u00f1\u00f3nez-Bastidas GN, Caram-Salas NL, Ambriz-Tututi M, Araiza-Salda\u00f1a CI, Rocha-Gonz\u00e1lez HI, Medina-Santill\u00e1n R, Reyes-Garc\u00eda G, Granados-Soto V (2008) Synergistic antiallodynic interaction between Gabapentin or carbamazepine and either Benfotiamine or cyanocobalamin in neuropathic rats. Methods Find Exp Clin Pharmacol 30:431\u2013441","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"11198_CR60","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-2008-1065351","volume":"116","author":"H Stracke","year":"2008","unstructured":"Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG (2008) Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes 116:600\u2013605","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11198-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:56:10Z","timestamp":1761735370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11198-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11198"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11198-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a review study. The TUMS Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"26"}}